FYERS
Home
/
Stocks
/
Results
/
Kilitch Drugs (India) Results

Kilitch Drugs (India) Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
27%28%19%19%
-52%42%18%
27%15%23%-3%
5%9%11%12%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
LUPIN
MANKIND
DRREDDY
AUROPHARMA
KILITCH-BE
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,916₹463791 Cr38.3412.0762.82₹11479 Cr
9,250₹245081 Cr83.7934.04128.41₹2568 Cr
4,905.5₹190351 Cr87.2816.7297.06₹2163 Cr
1,143₹114833 Cr25.449.4262.53₹5040 Cr
1,394.7₹114163 Cr33.879.7757.87₹3879 Cr
1,868.5₹100660 Cr92.066.829.25₹889 Cr
2,132₹98431 Cr17.830.95154.36₹5333 Cr
2,368.8₹98305 Cr48.1313.7571.08₹1913 Cr
1,155₹96906 Cr30.075.3263.99₹4196 Cr
1,637.3₹95300 Cr25.6717.9596.84₹3505 Cr
173.4₹599 Cr19.940.839.7₹30 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Sep 2012Jun 2012Sep 2011Jun 2011Jun 2010
₹45 Cr₹90 Cr₹54 Cr₹49 Cr₹43 Cr₹61 Cr₹56 Cr₹47 Cr₹33 Cr₹45 Cr₹32 Cr₹41 Cr₹37 Cr₹45 Cr₹30 Cr₹31 Cr₹33 Cr₹37 Cr₹34 Cr₹24 Cr₹20 Cr₹20 Cr₹20 Cr₹18 Cr₹10 Cr₹12 Cr₹16 Cr₹15 Cr₹10 Cr₹19 Cr₹8 Cr₹27 Cr₹28 Cr₹7 Cr₹15 Cr₹33 Cr₹31 Cr₹32 Cr
₹3 Cr₹49 L₹2 Cr₹7 Cr₹3 Cr₹2 Cr₹2 Cr₹5 Cr₹3 Cr₹47 L₹3 Cr₹49 L₹56 L₹1 Cr₹69 L₹24 L₹97 L₹38 L₹1 Cr₹17 L₹1 Cr₹2 Cr₹37 L₹42 L₹37 L₹1 Cr₹69 L₹59 L₹1 Cr-₹62 L₹33 L₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹23 L₹3 L₹0
₹48 Cr₹90 Cr₹55 Cr₹56 Cr₹46 Cr₹63 Cr₹58 Cr₹53 Cr₹36 Cr₹45 Cr₹35 Cr₹42 Cr₹37 Cr₹46 Cr₹31 Cr₹31 Cr₹34 Cr₹37 Cr₹36 Cr₹24 Cr₹21 Cr₹21 Cr₹21 Cr₹18 Cr₹11 Cr₹13 Cr₹17 Cr₹16 Cr₹12 Cr₹19 Cr₹9 Cr₹29 Cr₹30 Cr₹9 Cr₹19 Cr₹34 Cr₹31 Cr₹32 Cr
₹43 Cr₹68 Cr₹49 Cr₹45 Cr₹41 Cr₹47 Cr₹48 Cr₹42 Cr₹33 Cr₹39 Cr₹30 Cr₹33 Cr₹31 Cr₹40 Cr₹27 Cr₹28 Cr₹31 Cr₹33 Cr₹34 Cr₹21 Cr₹19 Cr₹20 Cr₹18 Cr₹16 Cr₹12 Cr₹14 Cr₹15 Cr₹14 Cr₹12 Cr₹17 Cr₹12 Cr₹23 Cr₹25 Cr₹9 Cr₹16 Cr₹27 Cr₹26 Cr₹27 Cr
₹6 Cr₹23 Cr₹8 Cr₹12 Cr₹6 Cr₹16 Cr₹10 Cr₹11 Cr₹4 Cr₹8 Cr₹5 Cr₹9 Cr₹7 Cr₹7 Cr₹5 Cr₹4 Cr₹4 Cr₹5 Cr₹2 Cr₹4 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr-₹74 L-₹83 L₹2 Cr₹2 Cr₹65 L₹2 Cr-₹3 Cr₹6 Cr₹6 Cr₹17 L₹3 Cr₹8 Cr₹6 Cr₹7 Cr
₹88 L₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹1 Cr₹31 L₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹67 L₹71 L₹24 L₹12 L₹13 L₹16 L₹12 L₹18 L₹29 L₹23 L₹17 L₹16 L₹15 L₹38 L₹0₹0₹0₹4 L₹3 L₹18 L₹1 Cr₹77 L
₹4 Cr₹20 Cr₹6 Cr₹9 Cr₹3 Cr₹14 Cr₹8 Cr₹10 Cr₹2 Cr₹5 Cr₹3 Cr₹7 Cr₹4 Cr₹5 Cr₹2 Cr₹2 Cr₹3 Cr₹4 Cr₹2 Cr₹3 Cr₹1 Cr₹1 Cr₹3 Cr₹3 Cr-₹2 Cr-₹2 Cr₹1 Cr₹2 Cr₹6 L₹1 Cr-₹4 Cr₹6 Cr₹5 Cr-₹21 L₹3 Cr₹6 Cr₹4 Cr₹5 Cr
₹2 Cr₹15 Cr₹4 Cr₹8 Cr₹2 Cr₹10 Cr₹6 Cr₹9 Cr₹11 L₹4 Cr₹2 Cr₹5 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹61 L₹3 Cr₹72 L₹71 L₹2 Cr₹2 Cr-₹1 Cr-₹1 Cr₹95 L₹1 Cr-₹19 L₹50 L-₹5 Cr₹4 Cr₹4 Cr-₹23 L₹3 Cr₹5 Cr₹3 Cr₹4 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Trade Payables
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2012Mar 2011Mar 2010
———————————————
₹35 Cr₹16 Cr₹16 Cr₹16 Cr₹16 Cr₹15 Cr₹15 Cr₹15 Cr₹14 Cr₹13 Cr₹13 Cr₹13 Cr₹13 Cr₹13 Cr₹13 Cr
₹35 L₹35 L₹35 L₹5 Cr₹3 Cr₹35 L₹1 Cr₹1 Cr₹4 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr
₹244 Cr₹186 Cr₹160 Cr₹131 Cr₹121 Cr₹111 Cr₹102 Cr₹105 Cr₹95 Cr₹87 Cr₹94 Cr₹105 Cr₹100 Cr₹69 Cr₹60 Cr
₹244 Cr₹186 Cr₹160 Cr₹131 Cr₹121 Cr₹111 Cr₹102 Cr₹105 Cr₹95 Cr₹87 Cr₹94 Cr₹105 Cr₹100 Cr₹69 Cr₹60 Cr
₹280 Cr₹202 Cr₹176 Cr₹152 Cr₹139 Cr₹127 Cr₹118 Cr₹121 Cr₹112 Cr₹101 Cr₹109 Cr₹120 Cr₹115 Cr₹84 Cr₹75 Cr
-₹3 Cr-₹2 Cr-₹62 L-₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹73 L₹0₹0₹0₹1 Cr₹2 Cr₹0
₹59 Cr₹28 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹4 L₹0₹43 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹1 L₹0
-₹5 Cr-₹3 Cr-₹3 Cr-₹2 Cr-₹2 Cr-₹1 Cr-₹97 L-₹1 Cr-₹2 Cr-₹2 Cr-₹95 L-₹51 L₹26 L₹51 L-₹5 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹37 L₹38 L₹0
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹15 L₹0₹0
₹68 L₹25 L₹17 L₹7 L₹28 L₹38 L₹39 L₹41 L₹0₹0₹0₹0₹0₹0₹0
₹55 Cr₹25 Cr-₹2 Cr-₹2 Cr-₹1 Cr-₹90 L-₹58 L-₹62 L-₹2 Cr-₹2 Cr-₹95 L-₹51 L₹82 L₹89 L₹38 Cr
———————————————
₹80 Cr₹54 Cr₹26 Cr₹41 Cr₹43 Cr₹54 Cr₹7 Cr₹4 Cr₹8 Cr₹6 Cr₹4 Cr₹2 Cr₹4 Cr₹10 Cr₹12 Cr
₹3 Cr₹33 L₹28 L₹25 L₹57 L₹1 Cr₹1 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹1 Cr₹38 Cr₹2 Cr
₹30 Cr₹22 Cr₹32 Cr₹22 Cr₹20 Cr₹15 Cr₹13 Cr₹9 Cr₹92 L₹69 L₹19 L₹10,000₹9 Cr₹16 Cr₹0
₹9 Cr₹8 Cr₹7 Cr₹6 Cr₹5 Cr₹3 Cr₹1 Cr₹2 Cr₹3 Cr₹2 Cr₹77 L₹55 L₹47 Cr₹2 Cr₹7 Cr
₹122 Cr₹84 Cr₹64 Cr₹69 Cr₹69 Cr₹73 Cr₹22 Cr₹20 Cr₹15 Cr₹12 Cr₹8 Cr₹7 Cr₹60 Cr₹66 Cr₹21 Cr
₹453 Cr₹310 Cr₹237 Cr₹218 Cr₹208 Cr₹202 Cr₹142 Cr₹143 Cr₹126 Cr₹110 Cr₹116 Cr₹126 Cr₹177 Cr₹153 Cr₹135 Cr
₹76 L₹76 L₹76 L₹76 L₹76 L₹76 L₹6 Cr₹6 Cr₹6 Cr₹5 Cr₹6 Cr₹6 Cr₹8 Cr₹4 Cr₹3 Cr
₹89 Cr₹49 Cr₹32 Cr₹22 Cr₹20 Cr₹15 Cr₹13 Cr₹9 Cr₹92 L₹69 L₹19 L₹10,000₹9 Cr₹53 Cr₹43 Cr
———————————————
₹124 Cr₹118 Cr₹112 Cr₹111 Cr₹108 Cr₹71 Cr₹71 Cr₹69 Cr₹68 Cr₹66 Cr₹66 Cr₹23 Cr₹21 Cr₹74 Cr₹71 Cr
₹57 Cr₹54 Cr₹50 Cr₹47 Cr₹44 Cr₹41 Cr₹39 Cr₹37 Cr₹35 Cr₹33 Cr₹23 Cr₹13 Cr₹12 Cr₹32 Cr₹27 Cr
₹67 Cr₹64 Cr₹62 Cr₹64 Cr₹65 Cr₹30 Cr₹32 Cr₹32 Cr₹33 Cr₹33 Cr₹42 Cr₹9 Cr₹9 Cr₹42 Cr₹44 Cr
₹140 Cr₹47 Cr₹6 Cr₹4 Cr₹3 Cr₹65 Cr₹30 Cr₹20 Cr₹3 Cr₹66 L₹0₹0₹0₹43 Cr₹22 Cr
₹23 Cr₹23 Cr₹23 Cr₹23 Cr₹24 Cr₹24 Cr₹24 Cr₹25 Cr₹26 Cr₹27 Cr₹26 Cr₹47 Cr₹72 L₹22 L₹1 Cr
₹23 Cr₹23 Cr₹23 Cr₹23 Cr₹24 Cr₹24 Cr₹24 Cr₹25 Cr₹26 Cr₹27 Cr₹26 Cr₹47 Cr₹72 L₹22 L₹1 Cr
₹1 Cr₹1 Cr₹72 L₹62 L₹46 L₹44 L₹36 L₹34 L₹22 L₹8 L₹20 L₹23 Cr₹25 L₹19 L₹0
₹50,000₹2 L₹1 L₹2 L₹2 Cr₹2 Cr₹54 L₹0₹79 L₹79 L₹0₹0₹0₹0₹0
₹231 Cr₹136 Cr₹92 Cr₹91 Cr₹94 Cr₹122 Cr₹86 Cr₹78 Cr₹63 Cr₹62 Cr₹68 Cr₹79 Cr₹10 Cr₹85 Cr₹67 Cr
———————————————
₹52 Cr₹50 Cr₹49 Cr₹39 Cr₹47 Cr₹36 Cr₹28 Cr₹28 Cr₹30 Cr₹26 Cr₹23 Cr₹25 Cr₹138 Cr₹25,000₹0
₹12 Cr₹15 Cr₹4 Cr₹2 Cr₹5 Cr₹4 Cr₹6 Cr₹5 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹17 Cr₹12 Cr
₹120 Cr₹85 Cr₹63 Cr₹54 Cr₹41 Cr₹23 Cr₹16 Cr₹19 Cr₹21 Cr₹15 Cr₹16 Cr₹13 Cr₹15 Cr₹39 Cr₹48 Cr
₹17 Cr₹10 Cr₹20 Cr₹20 Cr₹10 Cr₹13 Cr₹3 Cr₹8 Cr₹5 Cr₹2 Cr₹3 Cr₹5 Cr₹12 Cr₹9 Cr₹4 Cr
₹76 L₹6 Cr₹2 Cr₹54 L₹36 L₹5 L₹4 L₹16 L₹36 L₹7 L₹3 L₹7 L₹51 L₹100 L₹5 L
₹21 Cr₹8 Cr₹8 Cr₹10 Cr₹10 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹22 L₹1 Cr₹3 Cr
₹222 Cr₹174 Cr₹146 Cr₹126 Cr₹114 Cr₹80 Cr₹56 Cr₹65 Cr₹63 Cr₹49 Cr₹47 Cr₹47 Cr₹167 Cr₹68 Cr₹67 Cr
₹101 Cr₹90 Cr₹82 Cr₹58 Cr₹45 Cr₹7 Cr₹34 Cr₹45 Cr₹48 Cr₹37 Cr₹39 Cr₹40 Cr₹107 Cr₹1 Cr₹46 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹3 L₹3 L₹0₹0₹36 L
₹453 Cr₹310 Cr₹237 Cr₹218 Cr₹208 Cr₹202 Cr₹142 Cr₹143 Cr₹126 Cr₹110 Cr₹116 Cr₹126 Cr₹177 Cr₹153 Cr₹135 Cr
₹80₹126₹109₹94₹87₹82₹76₹78₹79₹75₹81₹90₹86₹62₹55
₹80₹61₹107₹94₹87₹82₹76₹78₹79₹75₹81₹90₹86₹62₹55

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent of Subsidiaries under liquidations
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2012Mar 2011Mar 2010
₹39 Cr₹34 Cr₹19 Cr₹12 Cr₹10 Cr₹5 Cr₹2 Cr₹9 Cr₹6 Cr-₹9 Cr-₹12 Cr-₹95 L-₹10 Cr₹13 Cr₹14 Cr
₹8 Cr₹1 Cr₹10 Cr₹10 Cr₹4 Cr₹3 Cr-₹1 Cr₹2 Cr₹2 Cr₹11 Cr₹9 Cr₹2 Cr₹7 Cr₹9 Cr₹7 Cr
-₹12 Cr-₹10 Cr-₹24 Cr-₹15 Cr-₹5 Cr₹39 Cr₹6 Cr-₹6 Cr-₹7 Cr-₹1 Cr₹20 Cr-₹9 Cr-₹27 Cr-₹17 L-₹5 Cr
₹34 Cr₹26 Cr₹6 Cr₹7 Cr₹8 Cr₹47 Cr₹7 Cr₹4 Cr₹1 Cr₹1 Cr₹17 Cr-₹8 Cr-₹29 Cr₹22 Cr₹15 Cr
₹24 Cr₹18 Cr-₹2 Cr₹3 Cr₹6 Cr₹46 Cr₹4 Cr₹29 L₹1 Cr₹1 Cr₹17 Cr-₹8 Cr-₹29 Cr₹22 Cr₹12 Cr
-₹100 Cr-₹40 Cr-₹8 Cr₹8 Cr-₹15 Cr-₹38 Cr-₹10 Cr-₹14 Cr-₹4 Cr-₹2 Cr-₹20 Cr-₹31 Cr₹41 Cr-₹24 Cr-₹20 Cr
₹82 Cr₹13 Cr₹9 Cr-₹72 L₹7 Cr₹2 Cr₹85 L₹17 Cr₹6 Cr-₹4 L₹11 L-₹6 L-₹9 Cr₹7 Cr₹7 Cr
₹6 Cr-₹9 Cr-₹88 L₹10 Cr-₹2 Cr₹10 Cr-₹5 Cr₹3 Cr₹2 Cr-₹45 L-₹2 Cr-₹39 Cr₹2 Cr₹6 Cr-₹1 Cr
₹10 Cr₹19 Cr₹20 Cr₹10 Cr₹13 Cr₹3 Cr₹8 Cr₹5 Cr₹2 Cr₹3 Cr₹5 Cr₹44 Cr₹9 Cr₹4 Cr₹5 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0-₹70,000₹0₹0₹0₹0
₹16 Cr₹10 Cr₹19 Cr₹20 Cr₹10 Cr₹13 Cr₹3 Cr₹8 Cr₹5 Cr₹2 Cr₹3 Cr₹5 Cr₹12 Cr₹9 Cr₹4 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)172.80
Volume (₹)9,031.00
High (₹)177.00
Upper Circuit181.14
Low (₹)172.80
Lower Circuit163.90
Prev Close172.52
52W High (₹)219.50
Price175.50
52W Low (₹)117.25

Share Market Cap & Key Ratios Overview

M.Cap (₹)599.77 Cr
Div. Yield (%)0.00
PE Ratio19.96
Debt to Equity0.32
Price to Book1.60
Book Value79.89
EPS (TTM)8.60
Face Value10.00
ROE (%)12.26

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
KILITCH-BENSE
LTP
1W Low
1W High
Market cap (₹)
1905.6-14.4 (-0.75%)
1902
1984.80
4,56,833Cr
9213.5-25.5 (-0.28%)
9087
9467
2,45,426Cr
4894-156 (-3.09%)
4885
5066
1,87,320Cr
1133.8-57.2 (-4.80%)
1125.10
1187
1,13,217Cr
1391-32.5 (-2.28%)
1376.70
1426.10
1,12,212Cr
1854.2-84.3 (-4.35%)
1811.70
1949
1,01,155Cr
2122.2-49.3 (-2.27%)
2118.10
2192
97,626Cr
2350.6-32.3 (-1.36%)
2341.20
2419.20
96,859Cr
1163.5-14.5 (-1.23%)
1154.40
1179.90
96,406Cr
1656.5+11.2 (0.68%)
1622.60
1717
93,614Cr
175.5+3.73 (2.17%)
166.15
177.25
600Cr

Kilitch Drugs (India) Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹5.83Cr; with other income of ₹2.9Cr, profit before interest and tax came to ₹4.74Cr. Interest expense was ₹87.6Lakh; PBT before exceptional items stood at ₹3.86Cr. Cost mix (full year): raw materials ₹125.07Cr; employee cost ₹14.31Cr; depreciation ₹1.09Cr; other expenses ₹41.94Cr. Basis: consolidated annual results.

Kilitch Drugs (India) Ltd Quaterly Results Key Takeaways

Kilitch Drugs (India) Ltd reported ₹44.88Cr total income from operations in Jun 2026, softer than ₹89.6Cr in Mar 2026 but higher than ₹43.14Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹5.83Cr; with other income of ₹2.9Cr, profit before interest and tax came to ₹4.74Cr. Interest expense was ₹87.6Lakh, taking profit before tax to ₹3.86Cr. After tax of ₹1.9Cr, profit after tax stood at ₹1.97Cr (vs ₹14.88Cr in Mar 2026 and ₹2.26Cr in Jun 2025).